Table 1.
Antimicrobial resistance of Salmonella spp. isolated from raw beef samples at Wolaita Sodo municipal abattoir, 2016
| Antimicrobial drugs | Salmonella spp. isolates | ||
|---|---|---|---|
| S (%) | I (%) | R (%) | |
| GEN | 31 (55.4%) | 18 (32.1%) | 7 (12.5%) |
| TE | 6 (10.7%) | 3 (5.4%) | 47 (83.9%) |
| AMP | 21 (37.5%) | 9 (2.6%) | 26 (46.4%) |
| AMC | 18 (32.1%) | 14 (25%) | 24 (42.9%) |
| CIP | 49 (87.5%) | 3 (5.4%) | 4 (7.1%) |
| CHL | 8 (14.3%) | 19 (33.9%) | 29 (51.8%) |
| F | 3 (5.4%) | 12 (21.4%) | 41 (73.2%) |
| S | 10 (17.9%) | 9 (2.6%) | 37 (66.1%) |
| K | 10 (17.9%)) | 17 (30.4%) | 29 (51.8%)) |
| CRO | 33 (58.91%) | 10 (17.9%) | 13 (23.2%) |
| NA | 18 (32.1%) | 16 (28.6%) | 22 (39.3%) |
| DA | 17 (30.4%) | 18 (32.1%) | 21 (37.5%) |
| Total | 224 (33.3%) | 148 (22.0%) | 300 (44.6%) |
GEN gentamicin, TE tetracycline, AMP ampicillin, AMC amoxicillin-clavulanic acid, CIP ciprofloxacin, CHL chloramphenicol, F nitrofurantoin, S streptomycin, K kanamycin, CRO ceftriaxone, NA nalidixic acid, DA clindamycin